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Abstract
A capillary electrophoresis (CE) method for the characterization of recombinant NTPDase1, 2, and 3, and for assaying
NTPDase inhibitors has been developed performing the enzymatic reaction within the capillary. After hydrodynamic
injection of plugs of substrate solution with or without inhibitor in reaction buffer, followed by a suspension of an
enzyme-containing membrane preparation, and subsequent injection of another plug of substrate solution with or without
inhibitor, the reaction took place close to the capillary inlet. After 5 min, the electrophoretic separation of the reaction
products was initiated by applying a constant current of j60 mA. The method employing a polyacrylamide-coated
capillary and reverse polarity mode provided baseline resolution of substrates and products within a short separation time
of less than 7 min. A 50 mM phosphate buffer (pH 6.5) was used for the separations and the products were detected by
their UV absorbance at 210 nm. The MichaelisYMenten constants (Km) for the recombinant rat NTPDases 1, 2, and 3
obtained with this method were consistent with previously reported data. The inhibition studies revealed pronounced
differences in the potency of reactive blue 2, pyridoxalphosphate-6-azophenyl-20,40-disulfonic acid (PPADS), suramin,
and N
6-diethyl-b,g-dibromomethylene-ATP (ARL67156) towards the NTPDase isoforms. Notably, ARL67156 does not
inhibit all NTPDases, having only a minor inhibitory effect on NTPDase2. Dipyridamole is not an inhibitor of the
NTPDase isoforms investigated. The new method is fast and accurate, it requires only tiny amounts of material (nanoliter
scale), no sample pretreatment and can be fully automated; thus it is clearly superior to the current standard methods.
Abbreviations: ARL67156–N
6-diethyl-b,g-dibromomethylene-ATP; CE–capillary electrophoresis; CHO–Chinese ham-
ster ovary; EMMA–electrophoretically mediated microanalysis; (E)-NTPDase–(ecto)-nucleoside triphosphate diphospho-
hydrolase; I.S.–internal standard; PPADS–pyridoxalphosphate-6-azophenyl-20,40-disulfonic acid; RB2–reactive blue 2
Introduction
Extracellular nucleotides such as ATP, ADP, UTP, and
UDP can act on a variety of nucleotide receptors (P2
receptors) [1]. The activation of P2 receptors is controlled
by ecto-nucleotidases capable of hydrolyzing nucleoside
tri- and diphosphates [2]. Inhibition of ecto-nucleotidases
can result in a potentiation of purinergic signaling,
supporting the notion that endogenous ecto-nucleotidases
reduce the effective concentration of the released nucleo-
tide [3Y5]. Similarly, metabolically stable analogs of ATP
are considerably more effective in causing a biological
response than ATP itself (for references see [6]). Inhibitors
of ecto-nucleotidases could thus represent valuable tools
for amplifying the biological effects induced by extracel-
lularly released nucleotides. In addition, inhibition of ecto-
nucleotidases is mandatory for both, studies of nucleotide
release and the analysis of the potency on P2 receptors of
nucleotides or their hydrolyzable analogs.
Inhibitors of ecto-nucleotidases should have no effect on
P2 receptors and should not be dephosphorylated by ecto-
nucleotidase. Ideally they would also reveal selectivity for
individual E-NTPDase isoforms. Many inhibitors of P2
receptors also act as inhibitors of ecto-nucleotidases. These
include suramin, pyridoxalphosphate-6-azophenyl-20,40-
disulfonic acid (PPADS) and reactive blue 2 (for references
see [6]) (Figure 1). To date only the ATP analog
ARL67156 (FPL67156, N
6-diethyl-b,g-dibromomethy-
lene-ATP, Figure 1) [4, 7] and 8-thiobutyladenosine 50-
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DOI: 10.1007/s11302-005-8076-xtriphosphate (8-Bu-S-ATP) [8] reveal enzyme inhibitory
potential without signiﬁcantly affecting nucleotide recep-
tors. However, these compounds have not been tested on
deﬁned NTPDase isoforms. The development of novel
inhibitors of ecto-nucleotidases requires fast and precise
methods for analyzing catalytic activity.
Capillary electrophoresis (CE) has recently emerged as a
versatile technique for enzyme assays [9]. CE systems have
been successfully applied for assaying enzyme activity
[10Y12], including the determination of MichaelisYMenten
constants (Km values) [13], and inhibition constants (Ki
values for enzyme inhibitors) [14], exhibiting a number of
advantages over conventional methods. These include
rapid separation of substrate and product, ultra-low sample
volume requirements, and high throughput by automation.
CE is particularly useful for investigating enzymatic
reactions involving charged substrates or products, e.g.,
for the monitoring of phosphorylation or dephosphoryla-
tion reactions [15Y17]. Electrophoretically mediated micro-
analysis (EMMA), ﬁrst described by Bao and Regnier [18]
has been successfully used for in-line enzyme assays [19]. In
this technique, the capillary is used as a microbioreactor as
well as for the separation of substrates and products. There
are two major types of EMMA methods. In the ﬁrst
continuous format [18], the capillary is ﬁlled with an
appropriate substrate solution and upon injection of a zone
of enzyme, the product will continuously form during the
electrophoretic mixing of enzyme and substrate. One
drawback of this method is that the separation buffer has
to allow the enzymatic reaction to proceed.
In the second plugYplug technique [20], substrate and
enzyme are introduced into the capillary as distinct plugs.
Upon application of an electric potential, these zones mix
with each other due to differences in their electrophoretic
mobilities. The reaction proceeds during the mixing
process. The resultant product is transported to the detector
separately from enzyme and educts under the inﬂuence of
an applied voltage, where they are individually detected.
Even double enzyme-catalyzed reactions were studied by
the latter method by injecting plugs of substrate and two
different enzymes separately in reaction buffer. This
technique was used to study the enzymatic reactions of
hexokinase and apyrase as well as lactate dehydrogenase
and glucose-6-phosphate dehydrogenase [21, 22].
In the present study, a method for analyzing the
enzymatic reactions of NTPDase1, 2 and 3, three surface-
located members of the ecto-nucleoside triphosphate
diphosphohydrolase family (EC 3.6.1.5) [2] has been
developed, performing the enzymatic reaction inside the
capillary at the capillary inlet followed by electrophoretic
separation of the reaction products. In the at-capillary inlet
reaction technique, the plugs of enzyme, substrate and
inhibitor are introduced into the capillary, where they are
allowed to react by simple diffusion and not by voltage as
in EMMA according to a previously described procedure
for angiotensin-converting enzyme assays [23, 24].
Materials and methods
Reagents and chemicals
Reactive blue 2, suramin, pyridoxalphosphate-6-azo-
phenyl-20,40-disulfonic acid (PPADS), dipyridamole and
4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid
Figure 1. Structures of investigated NTPDase inhibitors.
350 J. Iqbal et al.(HEPES) were obtained from Sigma, Steinheim, Germany.
ARL-67156 was from Tocris Cookson, Bristol, UK. ATP,
ADP, AMP, UMP, MgCl2I6H2O, and tris(hydroxymethyl)-
aminomethane (Trizma Base), were from Sigma (Tauf-
kirchen, Germany). Culture medium was obtained from
Invitrogen (Karlsruhe, Germany). Penicillin and strepto-
mycin were purchased from Sigma-Aldrich (Deisenhofen,
Germany). Leupeptin, pepstatin A, chymostatin, and anti-
pain were from Calbiochem (Schwalbach, Germany).
Cell transfection and preparation of membrane fractions
containing NTPDases
Chinesehamster ovary (CHO)cells were cultured in HAM’s
F-12 medium containing 10% fetal calf serum, 100 U/ml
penicillin and 100 mg/ml streptomycin. They were trans-
fected by electroporation with plasmid-DNA containing rat
NTPDase1 (GenBank Accession number U81295) [25],
NTPDase2 (Y11835) [25], and NTPDase3 (AJ437217)
[26], all cloned into the pcDNA3 plasmid. Transfection
with the empty plasmid pcDNA3 served as a control.
Transiently transfected CHO cells were used for prepara-
tion of membrane fractions 48 h after electroporation.
After removal of culture medium, cells were washed
twicewith buffer A(in mM:140NaCl,5KCl,0.5EDTA,20
Hepes, pH 7.4) and scraped off with 5 ml of ice-cold buffer
B (in mM: 140 NaCl, 5 KCl, 20 Hepes, pH 7.4) containing
protease inhibitors (in mg/ml: 2, chymostatin; 1, pepstatin A;
150 benzamidine; 2, antipain; 2, leupeptin) and iodoaceta-
mide (2 mM). Cells were centrifuged at 300 gav for 10 min
at 4 -C. The cell pellet was resuspended in buffer B,
homogenized using a PotterYElvehjem homogenizer and
sonicated. The homogenate was centrifuged for 10 min at
300 gav at 4 -C and the resulting supernatant fraction was
centrifuged at 100,000 gav for 1 h at 4 -C. The pellet
fraction was resuspended in buffer C containing 50% (v/v)
glycerol, 2 mM iodoacetamide, 20 mM Hepes (pH 7.4),
and stored at j20 -C. ATPase activity of individual mem-
brane fractions was determined by analysis of free phos-
phate formed according to Lanzetta et al. [27]. Protein was
determined according to the method of Spector [28]. The
membrane preparations contained 4Y6 mg of protein/ml.
CE instrumentation
All experiments were carried out using a P/ACE MDQ
capillary electrophoresis system (Beckman Instruments,
Fullerton, CA, USA) equipped with a UV detection system
coupled with a diode-array detector (DAD). Data collec-
tion and peak area analysis were performed by the P/ACE
MDQ software 32 KARAT obtained from Beckman
Coulter. The capillary temperature was kept constant at
37 -C. The temperature of the sample storing unit was ad-
justed to 10 -C. The electrophoretic separations were car-
ried out using an eCAP polyacrylamide-coated fused-silica
capillary [(30 cm (20 cm effective length)   50 mm internal
diameter (I.D.)   360 mm outside diameter (O.D.), obtained
from CS-Chromatographie (Langerwehe, Germany)]. The
separationwasperformedusinganappliedcurrentofj60mA
and a data acquisition rate of 8 Hz. Analytes were detected
using direct UV absorbance at 210 nm. The capillary was
conditioned by rinsing with water for 2 min and subse-
quently with buffer (phosphate 50 mM, pH 6.5) for 1 min.
Sample injections were made at the cathodic side of the
capillary.
At-inlet reaction procedure and automation of
analytical process
The CE running buffer consisted of dipotassium hydrogen
phosphate 50 mM, pH 6.5. The reaction buffer contained
140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2,
and 10 mM Hepes, pH 7.4. Before use, a new capillary
was washed with deionized water for 10 min. The au-
tomation cycle consisted of (1) washing with water for
2 min (40 p.s.i; 1 p.s.i = 6,894.76 Pa), (2) equilibration
with the CE running buffer for 1 min (40 p.s.i), (3)
injection of a plug of reaction solution containing 320 mM
ATP (substrate) in reaction buffer and various concen-
trations of inhibitor stock solutions in reaction buffer, (4)
injection of a plug of suitably diluted enzyme, (5) injection
of another plug of reaction solution as in (3), (6) and ﬁnally
injection of a plug of water. The plugs were then allowed
to react, while the capillary ends were dipped into water,
for a predetermined waiting period of 5 min. Then, a
current of j60 mA was applied and the reaction products
moved towards the detector end of the capillary. After each
analysis the capillary was rinsed with CE running buffer
for 2 min followed by deionized water for 1 min.
Each electropherogram was recorded over 7 min. The
diluted membrane fractions containing enzyme were
placed in the sample storage unit whose temperature was
kept constant at 10 -C. At this temperature, enzyme
activity remained unaffected during the approximately
24 h of instrument run. Substrate and buffers used in the
enzyme reaction were also kept at 10 -C in the autosampler
reservoir.
Quantitative determination of AMP and ADP and
method validation
AMP and ADP were dissolved in enzyme assay buffer (140
mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2,1 0m M
Hepes, pH 7.4) to obtain 1 mM stock solutions. Standard
calibration curves were obtained with ﬁnal concentrations
of 2, 5, 10, 20, 30, and 50 mM. For validating the method,
20 mM of UMP was used as an internal standard. A
polyacrylamide-coated capillary was used for the separa-
tion and quantitation of AMP and ADP. The procedure was
as described above using enzyme preparations inactivated
by heating to 99 -C for 3 min using an Eppendorf
Thermomixer Comfort. Determinations were performed in
triplicate. The calibration curves were obtained by plotting
the corrected peak area of AMP or ADP, respectively,
against their concentrations.
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reaction
For the determination of the IC50 and Ki values of
NTPDase inhibitors (Figure 1), 6Y8 different concentra-
tions of inhibitor spanning about three orders of magnitude
were used (see Figure 5Y7, while a ﬁxed substrate con-
centration of 320 mM of ATP was employed for all three
NTPDases. Under the applied conditions less than 10% of
substrate was converted by the enzymes. Membrane
preparations derived from transfected cells and containing
NTPDase1, NTPDase2, or NTPDase3, were appropriately
dilutedwithreactionbufferfortheinhibitionassays.Control
experiments were performed using membrane preparations
of cells transfected with the empty plasmid (pcDNA3).
Substrate and inhibitors were dissolved in the reaction
buffer containing 140 mM NaCl, 5 mM KCl, 1 mM MgCl2,
2m MC a C l 2, 10 mM Hepes, pH 7.4. The ChengYPrusoff
equation was used to calculate the Ki values from the IC50
values, determined by the non-linear curve ﬁtting program
PRISM 3.0 (GraphPad, San Diego, California, USA).
Ki ¼
IC50
1 þ
ATP ½ 
Km ATP ðÞ
MichaelisYMenten constant (Km) and maximal velocity
(Vmax) determination
For the determination of the MichaelisYMenten constants
(Km) and the maximum velocity (Vmax) eight different
substrate concentrations of ATP were used, 10, 20, 30, 50,
100, 200, 250 and 1000 mM of ATP for NTPDase1
dissolved in reaction buffer, while the following ATP
concentrations were used for NTPDase2 and 3: 25, 50, 100,
150, 200, 250, 300, 500 and 1000 mM. The capillary inlet
reaction method was used as described above.
Results
Development of the on-capillary reaction technique
The on-capillary reaction technique has previously been
successfully applied for inside capillary enzymatic reac-
tions using electrophoretically mediated microanalysis
(EMMA) [18, 19]. A related inside capillary enzymatic
reaction methodology in which the enzymatic reaction was
performed at the capillary inlet without electrophoretic
mixing of enzyme and substrate had been applied for the
determination of the MichaelisYMenten constant [23] and
for inhibition studies of the angiotensin-converting enzyme
[24]. In the present study we developed a CE method for
the monitoring of reactions of NTPDase1, 2 and 3 by a
modiﬁcation of the described at-capillary inlet enzymatic
reaction [23, 24]. Suitable conditions for the separation and
quantitative determination of nucleotides and the monitor-
ing of enzymatic nucleotide metabolism using CE had
previously been developed in our group [16, 17]. However
in those studies, the enzymatic reaction was performed in a
vial outside the capillary and the samples were injected
into the capillary and subjected to CE analysis only after
the enzymatic reaction had been stopped [16]. A modiﬁ-
cation of the developed separation protocols was now used
after performing the enzymatic reaction directly in the
capillary close to the capillary inlet. Thus, a small aliquot
of substrate-bearing reaction buffer was hydrodynamically
injected into the capillary followed by enzyme and then
again substrate, effectively sandwiching an aliquot of
enzyme on either side by substrate. After the ﬁnal plug of
substrate a small plug of water was injected resulting in a
stacking effect which improved the resolution of the peaks
[16]. The sandwich mode was required because otherwise
not enough product was formed. An inverse sandwich
mode of two plugs of enzyme on either side of substrate as
described by van Dyck et al. [24] for the reaction of
angiotensin converting enzyme, proved to be unfavorable
Figure 2. Schematic illustration of microscale reaction of NTPDases at capillary inlet. 1. Injection of a sample of 4 nl of 320 mM of ATP (substrate) in
reaction buffer containing UMP (20 mM) as an internal standard in the absence or presence of test compound (potential inhibitors) (0.3 p.s.i., 5 s);
2. Injection of enzyme (0.3 p.s.i., 5 s); 3. Injection of 320 mM of ATP (substrate) in reaction buffer containing UMP (20 mM) as an internal standard in
the absence or presence of test compound (0.3 p.s.i., 5 s); 4. Overlayed plugs are then allowed to stand during a predetermined period of 5 min;
5. Subsequently a j60 mA current is applied and the reaction products migrate to the detector. Electrophoresis conditions were as described in the
experimental section.
352 J. Iqbal et al.in our case since the rate of conversion of substrate to
product was more than 10%. Figure 2 provides a schematic
overview of the different steps of the capillary inlet
reaction procedure. A reaction buffer containing 140 mM
NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2 and 10 mM
Hepes, pH 7.4, was found suitable for the enzymatic
reaction, which was allowed to take place for 5 min. The
separation of substrate and product(s) was then initiated by
applying a constant current of j60 mA using a 50 mM
phosphate buffer (pH 6.5) resulting in a voltage of 7 kV.
The separation was completed within less than 6 min (see
Figure 3).
A wavelength of 210 nm was chosen for the detection of
the nucleotides due to the higher sensitivity that can be
reached at this wavelength in comparison with higher
wavelengths. The washing time and pressure had to be
optimized for the enzyme assay, because inside the
capillary there was a high concentration of salts, buffer
ions, lipids and proteins. A period of 2 min of washing with
buffer followed by 1 min with water at 40 p.s.i pressure
was found to be sufﬁcient for cleaning the capillary. In the
method described for monitoring angiotensin converting
enzyme [23, 24], van Dyck et al. had encountered some
drawbacks, such as unpredictable migration time shifts and
current breakdown. We believe that these problems were
due to the adsorption of enzyme to the capillary wall
because a fused silica capillary was used. In our study we
used a polyacrylamide-coated capillary, which is not
expected to show protein adsorption, thus we did observe
neither current breakdown nor unpredicted migration time
shifts. However, when we used a fused-silica capillary the
method was not successful due to the high concentration of
salts required in the reaction buffer and probably because
of enzyme and lipid adsorption to the capillary wall
resulting in peak broadening. Using a short, coated
capillary, high precision of migration time and very good
peak resolution was observed up to several hundreds of
runs.
Quantitative analysis of AMP and ADP
The NTPDase activity and inhibition was determined by
measuring the corrected peak area of AMP for NTPDase1,
and ADP for NTPDase2 and 3, respectively. Validation of
CE measurements of AMP and ADP were performed
exactly the same way as for enzyme activity assays, i.e.,
Figure 3. Overlay of ﬁve electropherograms after NTPDase3 on-line reaction at the capillary inlet with different concentrations of reactive blue 2
(inhibitor) added to the substrate plug. The concentration of NTPDase3 was 0.05 mg/ml of protein, ATP: 320 mM, UMP (internal standard): 40 mM.
Waiting period (duration of enzymatic reaction): 5.0 min. CE conditions: Running buffer: 50 mM potassium phosphate, pH 6.5; constant current of j60
mA; detection at 210 nm, capillary cartridge temperature: 37 -C. Reactive blue 2 (RB2) concentrations: a) 20, b) 6, c) 2, d) 0.6 and e) 0.2 mM. The lowest
concentration (0.2 mM) gave virtually the same electropherogram as the control without inhibitor.
Table 1. Limits of detection, limits of quantiﬁcation, migration times and linearity for AMP and ADP determination.
Compound AMP ADP
Limit of detection T SD (mg/ml) 0.80 T 0.20 0.36 T 0.10
Limit of quantiﬁcation T SD (mg/ml) 2.95 T 0.21 1.41 T 0.13
Linearity of calibration curve; R
2 0.998 0.999
Mean value of migration time T SD (min) (n = 12) 6.00 T 0.03 4.77 T 0.01
% RSD of migration time (min) 0.50 0.21
Regression equation y = 724.5x + 1.53, Sy,x = 775 y = 432.2x + 0.70, Sy,x = 241
SD = standard deviation, RSD = relative standard deviation.
CE assay for NTPDases 353(1) injection of plugs of different concentrations of AMP
or ADP in reaction buffer containing UMP (20 mM) as an
internal standard, (2) a suspension of a membrane prepa-
ration containing enzyme, followed by (3) another injec-
tion of AMP or ADP in reaction buffer containing UMP
(20 mM) as an internal standard. An overview of the quan-
titative parameters of the method validation is provided in
Table 1. A strictly linear correlation between AMP and
ADP concentrations and the corrected peak area ratio was
found: a correlation coefﬁcient (R
2) of 0.998 for AMP
and 0.999 for ADP (n = 3) was calculated for a concen-
tration range from 2.0 to 50.0 mM. The limit of quanti-
ﬁcation (LOQ) was found to be 2.95 mg/ml for AMP and
1.41 mg/ml for ADP. The limit of detection (LOD) of
AMP was determined to be 0.80 mg/ml for AMP and 0.36
mg/ml for ADP. Standard deviations were generally low
(Table 1).
Determination of MichaelisYMenten constant (Km) and
maximum velocity (Vmax)
The newly developed method was subsequently used to
characterize the catalytic properties of deﬁned members of
the E-NTPDase family. Using the optimized conditions,
MichaelisYMenten constants (Km) and maximal velocity
(Vmax) for NTPDases were determined. The enzyme
velocity was determined by measuring the peak areas of
the products of the enzymatic reaction. Km values were
obtained by using different concentrations of the substrate
ATP. Each substrate concentration was analyzed in
triplicate. The MichaelisYMenten plots are depicted in
Figure 4. Estimated Km values of 76, 203, and 311 mM
were obtained for NTPDase1, 2 and 3, respectively. The
initial reaction velocities were calculated from the amounts
of product formed, AMP in the case of NTPDase1 and
ADP in the case of NTPDase2 and 3. Vmax values were
0.023, 0.021 and 0.010 mmol/min/mg of protein (mem-
brane preparation) for NTPDase1, 2, and 3, respectively
(Table 2).
Development of an enzyme inhibition assay
Four selected NTPDase inhibitors were investigated: The
nucleotide analog ARL67156, the anthraquinone dye
reactive blue 2, the pyridoxal phosphate derivative PPADS,
and the symmetrical naphthalenesulfonic acid derivative
suramin (Figure 1). While ARL67156 has been reported to
be a weak but selective ectonucleotidase inhibitor without
signiﬁcant effects at P2 receptors, the other three com-
pounds are also antagonists at certain P2 receptors [4, 29].
Inhibition of NTPDases 1, 2 and 3 was determined by a
range of concentrations of inhibitors spanning three orders
of magnitude. The compounds entered the capillary inlet
together with the substrate by hydrodynamic injection and
the injected plugs of substrate/inhibitor and enzyme were
then allowed to react for 5 min. The compounds reacted
inside the capillary without applying any voltage, unlike in
EMMA, where compounds are mixed electrophoretically
by applying voltage before the reaction takes place. After
Table 2. Kinetic parameters of NTPDases.
NTPDase1 NTPDase2 NTPDase3
Km T SEM [mM] 76 T 12 203 T 8 311 T 4
Vmax T SEM
[mmol/min/mg
protein]
0.023 T 0.002 0.021 T 0.002 0.010 T 0.001
The results are means T SEM of three separate experiments each run in
duplicate.
Figure 4. MichaelisYMenten plots for the enzymatic reaction of
NTPDase1 (0), NTPDase2 (&) and NTPDase3 (Í) of initial ATP con-
centrations with respect to the reaction velocity for the determination of
Km and Vmax values by using in-capillary reaction at capillary inlet. For
enzyme activity assay see Materials and methods and for CE conditions
see Figure 3. Data points represent means T SD from three separate
experiments each run in duplicate. For determined Km and Vmax values see
Table 2.
Figure 5. Concentration-dependent inhibition of NTPDase1 by reactive
blue 2 (Í), ARL67156 (4) suramin (&) and PPADS (0) determined by
capillary electrophoresis using in-capillary reaction at capillary inlet,
using a substrate concentration of 320 mM ATP, a reaction buffer
consisting of 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2,
and 10 mM Hepes, pH 7.4, and various concentrations of inhibitor. The
separation conditions were 50 mM phosphate buffer, pH 6.5, neutral cap-
illary, 30 cm length (20 cm to the detector), 50 mM I.D.; j60 mA, 7 kV;
capillary cartridge temperature 37 -C; detection at 210 nm, pressure
injection. Data points represent means T SD from three separate experi-
ments, each run in duplicate.
354 J. Iqbal et al.the reaction, a constant current of j60 mA with reverse
polarity was applied to separate the reaction products. As
an example, an overlay of six electropherograms of the
NTPDase3 enzymatic reaction is shown in Figure 3, in
which the inhibitor concentration (reactive blue 2) was
varied from 0.2 to 20 mM and the concentration of ATP as
a substrate was ﬁxed at 320 mM. By increasing the con-
centration of the inhibitor reactive blue 2, the peak height
for ADP was decreased. Using NTPDase1, NTPDase2 and
NTPDase3 and the newly developed CE method, a
concentration-dependent inhibition by the standard inhib-
itors was observed for each of the enzymes (Figures 5Y7).
This allows a direct comparison of the effects of these
inhibitors on a variety of identiﬁed NTPDases. The Ki
values derived are summarized in Table 3.
The Ki values clearly show that the various NTPDases
are differentially susceptible to the individual inhibitors.
The values for reactive blue 2 were similar for NTPDase1
and 2, but lower by a factor of 20 for NTPDase3. Similarly,
Ki values for PPADS were similar for NTPDase1 and
NTPDase2 but 15-fold lower for NTPDse3. ARL67156
revealed the highest inhibitory potency for NTPDase1, was
considerably less effective on NTPDase3 and essentially
ineffective on NTPDase2. In contrast, suramin revealed the
lowest Ki values for NTPDase3 and was less effective on
NTPDase2 and NTPDase1. Dipyridamole was not an in-
hibitor of the E-NTPDases investigated.
Discussion
The ecto-nucleoside triphosphate diphosphohydrolases
(EC 3.6.1.5) represent a major and ubiquitous family
of ecto-nucleotidases. They catalyze the sequential hydro-
lysis of the g- and b-phosphate residues of nucleoside tri-
and diphosphates, producing the corresponding nucleoside
monophosphate derivatives [2]. To date four different cell
surface-located isoforms of the enzyme family have been
cloned and functionally characterized (NTPDase1, 2 and 3,
and very recently NTPDase8) [30Y32]. The four enzymes
differ in substrate speciﬁcity and in the pattern of product
formation. Whereas NTPDase1 hydrolyzes ATP and ADP
about equally well, NTPDase2 has a high preference for
the hydrolysis of ATP over ADP. NTPDase3 and NTP-
Dase8 are functional intermediates. NTPDase1 hydrolyzes
ATP directly to AMP, ADP is the preferential product of
ATP hydrolysis by NTPDase2, and NTPDase3 and
NTPDase8 hydrolyze ADP formed from ATP efﬁciently
to AMP.
In previous studies, a variety of compounds has been
tested regarding their potency for inhibiting ecto-nucleoti-
dases, often in intact tissues or on cells with undeﬁned
enzyme species. Only few studies have used recombinant
enzymes to clearly identify the isoform investigated [33,
34]. In addition, several methods have been used for the
determination of MichaelisYMenten constants (Km values),
and inhibition constants (Ki values for enzyme inhibitors)
of NTPDases, including radioisotopic [29], HPLC [35, 36]
and spectrophotometric assays [37]. All of these methods
Table 3. Ki values for NTPDase1, 2 and 3 obtained for reactive blue 2,
PPADS, suramin, and ARL67156, using the in-capillary electrophoresis
method.
Inhibitor
a Ki T SEM [mM]
NTPDase1 NTPDase2 NTPDase3
RB2 20.0 T 0.003 24.2 T 0.06 1.10 T 0.03
PPADS 46.0 T 0.01 44.2 T 0.03 3.0 T 0.001
Suramin 300 T 0.1 65.4 T 0.01 12.7 T 0.03
ARL 67156 27.0 T 0.004 Q 1000
b 112.1 T 0.05
Dipyridamole 9 1000
c 9 1000
c 9 1000
c
The results are means T SEM of three separate experiments each run in
duplicate.
aFor structures see Figure 1.
b50% inhibition at 1 mM concentration.
cNo inhibitory activity up to a concentration of 1 mM.
Figure 7. Concentration-dependent inhibition of NTPDase3 by reactive
blue 2 (Í), ARL67156 (4), suramin (&) and PPADS (0) determined by
capillary electrophoresis using in-capillary reaction at capillary inlet. For
CE and assay conditions see Figure 5. Data points represent means T SD
from three separate experiments each run in duplicate.
Figure 6. Concentration-dependent inhibition of NTPDase2 by reactive
blue 2 (Í) suramin (&) and PPADS (0) determined by capillary elec-
trophoresis using in-capillary reaction at capillary inlet. For CE and assay
conditions see Figure 5. Data points represent means T SD from three
separate experiments, each run in duplicates. ARL67156 (not shown) ex-
hibited only 50% inhibition at a concentration of 1 mM.
CE assay for NTPDases 355are time-consuming. Radiometric assays are very sensitive,
but require tedious procedures and the use of radiolabeled
substrates [29]. High performance liquid chromatography
suffers from relatively high prices for columns, buffers and
solvents; in addition, sample pretreatment to remove
proteins and lipids is required. Spectrophotometric meth-
ods [8, 37] require large amounts of material and are prone
to interference from other biological matrices. In addition,
the analysis of the total of free phosphate formed confuses
the additive contribution of the ATPase and ADPase
activity of the identical enzyme, if the nucleoside triphos-
phate is applied. Our newly developed in-capillary elec-
trophoresis method represents an easy, fast and convenient
method for analyzing ecto-nucleotidase activity, including
substrate analysis, enzyme kinetics, and the screening for
novel inhibitors.
The validity of the method is underpinned by a
comparison with previously obtained Km values. Reported
Km values vary between species and investigators. Since in
many cases the identity of the enzyme species was not
determined [6], the values cannot easily be related to our
data. However, the Km values we have obtained for the rat
orthologs of the enzymes are in very good agreement with
values obtained for the recombinant enzymes from other
species. Reported Km values (ATP, mM) are 17 for human
NTPDase1 [32] and 12 for mouse NTPDase1 [32]; 70, 210
and 394, respectively for human NTPDase2 [32, 38, 39]
and 37 for mouse NTPDase2; 75 and 128, respectively for
human NTPDase3 [32, 40] and 11 for mouse NTPDase3
[41]. Interestingly, the value obtained for rat NTPDase1 in
our study (76 mM) is in excellent agreement with a
previously reported value for recombinant rat NTPDase1
(75 mM, [42]). The Km values for NTPDase8, the most
recently cloned member of the enzyme family are within
the same range (13 mM for mouse and 46 mM for rat
NTPDase8) [30, 32].
Using identiﬁed enzyme species we can clearly show
that NTPDase1, 2 and 3 reveal a differential susceptibility
to inhibitors. An inhibitory effect of suramin [3, 29,
43Y49], of PPADS [29], of reactive blue 2 [29, 48Y50],
or of ARL67156 [4, 48, 51] on the hydrolysis of ATP by
mammalian ecto-nucleotidases has previously been report-
ed for various cellular systems. However, these studies did
not identify the NTPDase isoform(s) expressed nor did
they exclude a contribution to ATP hydrolysis by other
types of ecto-nucleotidases.
In our study, reactive blue 2, PPADS and suramin
inhibited NTPDase3 15- to 25-fold more effectively than
NTPDase1. NTPDase2 was inhibited by reactive blue 2
and PPADS to a similar extent as NTPDase1 but the Ki
value for suramin was ﬁve fold higher for NTPDase1. An
analysis of detergent-solubilized NTPDase1 and NTPDase2
puriﬁed from porcine brain, revealed Ki values (ATP) for
suramin of 1.8 mM and 2.1 mM, respectively [52]. These
values are much higher than those obtained for the
membrane-bound rat enzymes reported in this study. In
contrast to the other compounds tested, ARL67156
revealed the highest inhibitory potency for NTPDase1. It
was considerably less effective on NTPDase3 and essen-
tially ineffective on NTPDase2. Since ARL67156 is a
widely used inhibitor of Fecto-ATPase_ activity, this
observation is a caveat for experiments in which this
inhibitor is used without previous identiﬁcation of the
NTPDase involved. Dipyridamole was not an inhibitor of
the NTPDases investigated but in a previous study it was
found to be an effective inhibitor of ATP hydrolysis in rat
superior cervical ganglionic cells at 10 mM concentration
[53]. The compound has been found to be inactive in other
systems [e.g., 16].
In conclusion, we have developed a new method for the
characterization of E-NTPDases and the screening of
potential substrates and inhibitors using capillary electro-
phoresis coupled with UV detection. In order to deﬁne the
properties of individual isoforms, we determined the Km
values of heterologously expressed NTPDase1, NTPDase2
and NTPDase3 and the Ki values for selected inhibitors. By
using a neutral capillary, migration times of nucleotides
were decreased in comparison with a fused silica capillary
resulting in high reproducibility and precision of analysis.
The developed in-capillary electrophoresis method is an
easy, fast and convenient method for studying enzyme
kinetics, and for searching for substrates and novel
inhibitors.
The scale of the enzymatic reaction could be dramati-
cally reduced to the nanoliter scale as compared to off-line
analysis of the reaction carried out in a microcentrifuge
tube. Moreover, since the capillary is used as a reaction
vessel, all the assay steps (mixing, reaction, separation, and
quantitation) are combined in a fully automated microscale
activity assay. This process was carried out automatically
using a temperature-controlled autosampler in order to
eliminate routine handling and to speed-up the process.
The newly developed fast, easy and versatile screening
method will greatly facilitate the search for and develop-
ment of potent and selective ectonucleotidase inhibitors
which are urgently required for pharmacological studies.
Acknowledgements
N.B. and H.Z. were supported by a grant from the
Deutsche Forschungsgemeinschaft (SFB 269, A4). C.E.M.
is grateful for support by the Fonds der Chemischen
Industrie.
References
1. Ralevic V, Burnstock G. Receptors for purines and pyrimidines.
Pharmacol Rev 1998; 50: 413Y92.
2. Zimmermann H. Extracellular metabolism of ATP and other
nucleotides. NaunynYSchmiedeberg’s Arch Pharmacol 2000; 362:
299Y309.
3. Crack BE, Beukers MW, McKechnie KC et al. Pharmacological
analysis of ecto-ATPase inhibition: Evidence for combined enzyme
inhibition and receptor antagonism in P2X-purinoceptor ligands.
Br J Pharmacol 1994; 113: 1432Y8.
4. Crack BE, Pollard CE, Beukers MW et al. Pharmacological and
356 J. Iqbal et al.biochemical analysis of FPL 67156, a novel, selective inhibitor of
ecto-ATPase. Br J Pharmacol 1995; 114: 475Y81.
5. Bultmann R, Driessen B, Goncalves J, Starke K. Functional
consequences of inhibition of nucleotide breakdown in rat vas
deferens: A study with Evans blue. NaunynYSchmiedebergs Arch
Pharmacol 1995; 351: 555Y60.
6. Zimmermann, H. Ecto-nucleotidases. Purinergic and Pyrimidergic
Signalling. In Abbracchio MP, Williams M (eds): Handbook of
Experimental Pharmacology. Heidelberg: Springer 2001; 209Y50.
7. Kennedy C, Westfall TD, Sneddon P. Modulation of purinergic
neurotransmission by ecto-ATPase. Semin Neurosci 1996; 8: 195Y99.
8. Gendron FP, Halbﬁnger E, Fischer B et al. Novel inhibitors of
nucleoside triphosphate diphosphohydrolases: Chemical synthesis
and biochemical and pharmacological characterizations. J Med
Chem 2000; 43: 2239Y47.
9. Burns KL, May SW. Separation methods applicable to the evaluation
of enzyme-inhibitor enzyme-substrate interactions. J Chromatogr, B
Analyt Technol Biomed Life Sci 2003; 797: 175Y90.
10. Van Dyck S, Van Schepdael A, Hoogmartens J. Kinetic study of
gamma-glutamyltransferase activity by electrophoretically mediated
microanalysis combined with micellar electrokinetic capillary chro-
matography. Electrophoresis 2002; 23: 2854Y9.
11. Viglio S, Zanaboni G, Luisetti M et al. Micellar electrokinetic
chromatography: A convenient alternative to colorimetric and high
performance liquid chromatographic detection to monitor protease
activity. Electrophoresis 1998; 19: 2083Y9.
12. Dai HJ, Parker CN, Bao JJ. Characterization and inhibition study of
MurA enzyme by capillary electrophoresis. J Chromatogr, B Analyt
Technol Biomed Life Sci 2002; 766: 123Y32.
13. Kanie Y, Kanie O. Electrophoretically mediated reaction of gly-
cosidases at a nanoliter scale. Electrophoresis 2003; 24: 1111Y8.
14. Whisnant AR, Johnston SE, Gilman SD. Capillary electrophoretic
analysis of alkaline phosphatase inhibition by theophylline. Electro-
phoresis 2000; 21: 1341Y8.
15. Meredith GD, Sims CE, Soughayer JS, Allbritton NL. Measurement
of kinase activation in single mammalian cells. Nat Biotechnol 2000;
18: 309Y12.
16. Kaulich M, Qurishi R, Mu ¨ller CE. Extracellular metabolism of
nucleotides in neuroblastoma x glioma NG108-15 cells determined
by capillary electrophoresis. Cell Mol Neurobiol 2003; 23: 349Y64.
17. Qurishi R, Kaulich M, Mu ¨ller CE. Fast, efﬁcient capillary electro-
phoresis method for measuring nucleotide degradation and metabo-
lism. J Chromatogr A 2002; 952: 275Y81.
18. Bao J, Regnier FE. Ultramicro enzyme assays in a capillary
electrophoretic system. J Chromatogr 1992; 608: 217Y24.
19. Telnarova M, Vytiskova S, Monincova M, Glatz Z. Electrophoret-
ically mediated microanalysis with partial ﬁlling technique and
indirect or direct detection as a tool for inhibition studies of
enzymatic reaction. Electrophoresis 2004; 25: 1028Y33.
20. Telnarova M, Vytiskova S, Chaloupkova R, Glatz Z. Study of
enzymatic reaction by electrophoretically mediated microanalysis in
a partially ﬁlled capillary with indirect or direct detection. Electro-
phoresis 2004; 25: 290Y6.
21. Zhang Y, Kaddis J, Silverio C et al. On-column enzyme-catalyzed
microreactions using capillary electrophoresis: Quantitative studies.
J Capillary Electrophor 2002; 7: 1Y9.
22. Zhao DS, Gomez FA. Double enzyme-catalyzed microreactors using
capillary electrophoresis. Electrophoresis 1998; 19: 420Y6.
23. Van Dyck S, Vissers S, Van Schepdael A, Hoogmartens J. Kinetic
study of angiotensin converting enzyme activity by capillary elec-
trophoresis after in-line reaction at the capillary inlet. J Chromatogr
A 2003; 986: 303Y11.
24. Van Dyck S, Novakova S, Van Schepdael A, Hoogmartens J.
Inhibition study of angiotensin converting enzyme by capillary elec-
trophoresis after enzymatic reaction at capillary inlet. J Chromatogr
A 2003; 1013: 149Y56.
25. Kegel B, Braun N, Heine P et al. An ecto-ATPase and an ecto-ATP
diphosphohydrolase are expressed in rat brain. Neuropharmacology
1997; 36: 1189Y200.
26. Vorhoff T, Zimmermann H, Pelletier J, Sevigny J, Braun N. Cloning
and characterization of the ecto-nucleotidase NTPDase3 from rat
brain: Predicted secondary structure and relation to other members of
the E-NTPDase family and actin. Purinergic Signalling 2005; 1:
259Y70.
27. Lanzetta PA, Alvarez LJ, Reinach PS, Candia OA. An improved
assay for nanomole amounts of inorganic phosphate. Anal Biochem
1979; 100: 95Y7.
28. Spector T. Reﬁnement of the coomassie blue method of protein
quantitation. A simple and linear spectrophotometric assay for less
than or equal to 0.5 to 50 microgram of protein. Anal Biochem 1978;
86: 142Y6.
29. Chen BC, Lee CM, Lin WW. Inhibition of ecto-ATPase by PPADS,
suramin and reactive blue in endothelial cells, C6 glioma cells and
RAW 264.7 macrophages. Br J Pharmacol 1996; 119: 1628Y34.
30. Bigonnesse F, Levesque SA, Kukulski F et al. Cloning and
characterization of mouse nucleoside triphosphate diphosphohydro-
lase-8. Biochemistry 2004; 43: 5511Y9.
31. Zimmermann H. Ectonucleotidases: Some recent developments and
a note on nomenclature. Drug Dev Res 2001; 52: 44Y56.
32. Kukulski F, Le ´vesque SA, Lavoie E ´G et al. Comparative hydrolysis
of P2 receptor agonists by NTPDases 1, 2, 3 and 8. Purinergic
Signalling 2005; 1: 193Y204.
33. Heine P, Braun N, Heilbronn A, Zimmermann H. Functional
characterization of rat ecto-ATPase and ecto-ATP diphosphohydro-
lase after heterologous expression in CHO cells. Eur J Biochem
1999; 262: 102Y7.
34. Hoffmann C, Heine P, Pradel G et al. Inhibition of ecto-apyrase and
ecto-ATPase by pyridoxal phosphate-related compounds. Drug Dev
Res 2000; 51: 153Y8.
35. Heine P, BraunN, SevignyJ et al.The C-terminalcysteine-rich region
dictates speciﬁc catalytic properties in chimeras of the ecto-
nucleotidases NTPDase1 and NTPDase2. Eur J Biochem 2001; 268:
364Y73.
36. Mihaylova-Todorova ST, Todorov LD, Westfall DP. Enzyme
kinetics and pharmacological characterization of nucleotidases
released from the guinea pig isolated vas deferens during nerve
stimulation: Evidence for a soluble ecto-nucleoside triphosphate
diphosphohydrolase-like ATPase and a soluble ecto-50-nucleotidase-
like AMPase. J Pharmacol Exp Ther 2002; 302: 992Y1001.
37. Knowles AF, Nagy AK. Inhibition of an ecto-ATP-diphosphohy-
drolase by azide. Eur J Biochem 1999; 262: 349Y57.
38. Knowles AF, Chiang WC. Enzymatic and transcriptional regulation
of human ecto-ATPase/E-NTPDase 2. Arch Biochem Biophys 2003;
418: 217Y27.
39. Mateo J, Harden TK, Boyer JL. Functional expression of a cDNA
encoding a human ecto-ATPase. Br J Pharmacol 1999; 128: 396Y402.
40. Smith TM, Kirley TL. Site-directed mutagenesis of a human brain
ecto-apyrase: Evidence that the E-type ATPases are related to the
actin/heat shock 70/sugar kinase superfamily. Biochemistry 1999;
38: 321Y8.
41. Lavoie EG, Kukulski F, Levesque SA et al. Cloning and character-
ization of mouse nucleoside triphosphate diphosphohydrolase-3.
Biochem Pharmacol 2004; 67: 1917Y26.
42. Wang TF, Ou Y, Guidotti G. The transmembrane domains of
ectoapyrase (CD39) affect its enzymatic activity and quaternary
structure. J Biol Chem 1998; 273: 24814Y21.
43. Hourani SM, Chown JA. The effects of some possible inhibitors of
ectonucleotidases on the breakdown and pharmacological effects of
ATP in the guinea-pig urinary bladder. Gen Pharmacol 1989; 20:
413Y6.
44. Beukers MW, Kerkhof CJ, van Rhee MA et al. Suramin analogs,
divalent cations and ATP gamma S as inhibitors of ecto-ATPase.
NaunynYSchmiedeberg’s Arch Pharmacol 1995; 351: 523Y8.
45. Meghji P, Burnstock G. Inhibition of extracellular ATP degradation
in endothelial cells. Life Sci 1995; 57: 763Y71.
46. Bultmann R, Wittenburg H, Pause B et al. P2-purinoceptor antago-
nists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleoti-
dases by compounds related to suramin. NaunynYSchmiedeberg’s
Arch Pharmacol 1996; 354: 498Y504.
47. Bonan CD, Roesler R, Quevedo J et al. Effects of suramin on
hippocampal apyrase activity and inhibitory avoidance learning of
rats. Pharmacol Biochem Behav 1999; 63: 153Y8.
CE assay for NTPDases 35748. Dowd FJ, Li LS, Zeng W. Inhibition of rat parotid ecto-ATPase
activity. Arch Oral Biol 1999; 44: 1055Y62.
49. Yegutkin GG, Burnstock G. Inhibitory effects of some purinergic
agents on ecto-ATPase activity and pattern of stepwise ATP
hydrolysis in rat liver plasma membranes. Biochim Biophys Acta
2000; 1466: 234Y44.
50. Tuluc F, Bultmann R, Glanzel M et al. P2-receptor antagonists: IV.
Blockade of P2-receptor subtypes and ecto-nucleotidases by com-
pounds related to reactive blue 2. NaunynYSchmiedeberg’s Arch
Pharmacol 1998; 357: 111Y20.
51. Drakulich DA, Spellmon C, Hexum TD. Effect of the ecto-ATPase
inhibitor, ARL 67156, on the bovine chromafﬁn cell response to
ATP. Eur J Pharmacol 2004; 485: 137Y40.
52. Kukulski F, Komoszynski M. Puriﬁcation and characterization of
NTPDase1 (ecto-apyrase) and NTPDase2 (ecto-ATPase) from por-
cine brain cortex synaptosomes. Eur J Biochem 2003; 270: 3447Y54.
358 J. Iqbal et al.